Skip to content

Dr. Lorenzo Lefevere

Active Private limited companyfounded 2009active for 17 yearsHeerweg 1, 9667 HorebekeKBO/BCE: BE 0809.995.332

Lifetime

16 annual accounts with figures on one time axis
peak of €238,783 in 2010
€224,983▲ 22.0%
peak of €136,662 in 2025
€136,662▲ 22.7%
peak of €609,369 in 2024
€370,204▼ 39.2%
€318,633▲ 751%
Board1 name since 2022
1 director
Documentsfilings and deeds
16-12-202546 days before the deadline
2025micro format
Gross margin from €184,346 to €224,983Dividend €375,827Equity from €609,369 to €370,204Debts from €37,441 to €318,633Investments €100,028

Key points

from the 2025 annual accounts

Equity

€370,204 ▼ 39.2%
609,3692024+136,662Profit-375,827Dividend370,2042025

Dr. Lorenzo Lefevere paid out €375,827 in dividends. That is 275% of the 2025 profit.

Turnover

≈ €560,000 estimated

The micro format states no turnover.

Debts

€318,633 ▲ 751%
Other debts
+274,242
Taxes and wages
+8,962
The rest
-2,012

Debts rose by €281,192 in 2025. A dividend stands under other debts on the balance sheet date until it is paid.

Investments

€100,036 3.0 times depreciation
2022202320242025

Green is investment, beige is depreciation.

Liquidity

1.04 was 11.93 in 2024

Short-term debts rose from €29,100 to €311,713.

Filings

16 annual accounts since 2010
deadline2010201520202025

The last five annual accounts were filed 2 to 46 days before the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,816 companies had the same profile as Dr. Lorenzo Lefevere has now. Each dot stands for 45 companies, two years later.

96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,816 companies, not a prediction for Dr. Lorenzo Lefevere. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Board & ownership

Recent changes

changes role from statutory manager to statutory director Director discharge: · Gazette deed
Incorporation published on 04-03-2009 · Gazette deed
First establishment Heerweg 1, Horebeke
All 27 events

Official details

Source: KBO
Status
Active since 23-02-2009Normal situation
Activity
“Het tot stand brengen van een professionele vennootschap voor artsen-aandeelhouders binnen dewelke de artsen-aandeelhouders…” (deed in Dutch)From the articles, 4 activities1 activity on the establishment unit
Establishment unit
2.302.155.6369667 Horebeke, since 23-02-2009
Financial year end
30 June
Peppol
Not found in the Peppol Directory
Company details

Annual accounts to 30-06-2025

€688,837▲ 6.5%
Filing
Filed on 16-12-2025, 46 days before the end of the filing period
Financials

Insights on Dr. Lorenzo Lefevere

Dr. Lorenzo Lefevere files the micro format. That format states no turnover. The gross margin fell from €238,783 in 2010 to €224,983 in 2025.

The balance sheet grew most from 2017 to 2019 through fixed assets.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Lorenzo Lefevere

What is the company number of Dr. Lorenzo Lefevere?
The company number of Dr. Lorenzo Lefevere is 0809.995.332. The VAT number is the same number with BE in front: BE 0809.995.332.
Where is Dr. Lorenzo Lefevere based?
The registered office is at Heerweg 1, 9667 Horebeke.Company details
What is the legal form of Dr. Lorenzo Lefevere?
Dr. Lorenzo Lefevere is a private limited company (BV).
When was Dr. Lorenzo Lefevere founded?
Dr. Lorenzo Lefevere was founded on 23-02-2009.
Is Dr. Lorenzo Lefevere still active?
Yes, Dr. Lorenzo Lefevere is an active enterprise in the KBO register.
What is the turnover of Dr. Lorenzo Lefevere?
The turnover in financial year 2025 is ≈ €560,000. This figure is estimated from the gross margin of €224,983 and 2,459 comparable companies of the same size. It probably lies between €370,000 and €870,000. It is a rough estimate.Financials
Is Dr. Lorenzo Lefevere profitable?
In financial year 2025, Dr. Lorenzo Lefevere made a profit of €136,662.
Where can I find the annual accounts of Dr. Lorenzo Lefevere?
Dr. Lorenzo Lefevere filed 16 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Lorenzo Lefevere due?
Dr. Lorenzo Lefevere must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.